Source: Annual Congress 2004 - Pulmonary and respiratory pump function
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Yanardag, S. Uygun, T. Yanardag, Y. Karter, H. Mutlu (Istanbul, Turkey). Ortner‘s syndrome associated with secondary pulmonary hypertension. Eur Respir J 2004; 24: Suppl. 48, 466

Member's Comments

No comment yet.

Related content which might interest you: The metabolic syndrome and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene Source: Eur Respir J 2001; 17: 1065-1069 Year: 2001 Amfepramone does not cause primary pulmonary hypertension Source: Eur Respir J 2004; 23: 790 Year: 2004 TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020 Year: 2020 Portopulmonary hypertension: a further clue to pathogenesis? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012 Prevalence of hyperventilation syndrome in pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 D-dimers in patients with chronic obstructive pulmonary disease with or without secondary secondary erythrocytosis Source: Eur Respir J 2004; 24: Suppl. 48, 14s Year: 2004 Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004 Pulmonary arterial hypertension associated with congenital heart disease Source: Eur Respir Rev 2012 21: 328-337 Year: 2012 Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Does left heart disease cause most systemic sclerosis associated pulmonary hypertension? Source: Eur Respir J 2013; 42: 888-890 Year: 2013 Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival Source: Eur Respir J 2013; 42: 1271-1282 Year: 2013 Effect of sitaxentan in patients with pulmonary arterial hypertension associated to congenital heart diseases Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Abernethy syndrome: A rare cause of pulmonary hypertension Source: International Congress 2018 – Paediatric bronchology Year: 2018